¹⁸F-FDG PET in the diagnosis of large vessel vasculitis

Czech version

Authors: Z. Řehák ¹; Z. Fojtík ²; J. Staníček ¹; K. Bolčák ¹; L. Fryšáková ³
Authors‘ workplace: Oddělení nukleární medicíny Masarykova onkologického ústavu, Brno, přednosta prim. MUDr. Karol Bolčák ¹; Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc. ²; III. interní klinika Lékařské fakulty UP a FN Olomouc, přednosta prof. MUDr. Vlastimil Ščudla, CSc. ³
Published in: Vnitř Lék 2006; 52(11): 1037-1044
Category: Original Contributions

Overview

Introduction:
Positron emission tomography (PET) is a non-invasive diagnostic method which shows the bio-distribution of positron emitter labelled radiopharmaceuticals in the body. Due to the fact that not only timorous, but in certain conditions also some inflammatory cells may exhibit increased accumulation of 18F-FDG, 18F-FDG PET can be used in the diagnosis of both tumours and certain types of inflammations.

Objective:
The objective of the study is to asses the benefits of 18F-FDG PET in the patients examined for symptoms of fever of uncertain origin whose results suggested the possibility of large vessel vasculitis.

Sample and methods:
In the years 2003 and 2004, the positron emission tomography centre at Masaryk Oncological Institute in Brno examined 35 patients in order to establish the cause of febrilia using 18F-FDG PET. The suspicion of large vessel vasculitis was based on the detection of high accumulation of radiopharmaceuticals in large vessels walls (in the aorta and the larger outgoing branches). The patients underwent a further standard imaging test to diagnose large vessel vasculitis as follows: CT angiography (CTA) in 4 patients, MR angiography (MRA) in 3 patients and duplex ultrasonography (USG) in 7 patients. A definitive diagnosis of primary autoimmunity of large vessel vasculitis was counter checked histologically or based on a therapeutic test by means of the effect of corticotherapy in immunosuppressive doses.

Results:
Positive PET findings were recorded in 23 out of 35 patients (65.7 %). 11 out of 23 PET positive patients (47.8 % of PET positive persons and 31.4% of all patients with febrilia) were suspected to have active large vessel vasculitis based on PET examination. In 10 of the 11 patients, it was possible to perform additional examinations necessary to confirm the diagnosis: a histological test of arteria temporalis in one case, and a therapeutic test using corticotherapy in all 10 cases. Large vessel vasculitis was confirmed in all 10 individuals (2 men and 8 women aged 53–66, median age of 62 years). None of the CTA, MRA or USG examinations in any of the cases detected direct or clear signs of vasculitis, but 3 CTA and 1 MRA examinations could be considered abnormal. The detection of temporal (giant cell) arteritis based on excision of arteria temporalis superficialis points to the limits of PET examination which is unable to assess veins with a diameter of less than 5 mm. On the other hand, it documents the possibility of extra-cranial damage being proved in this diagnosis with the use PET. In seven of the ten cases, a control PET scan was done during corticotherapy. It showed a drop in the accumulation of radiopharmaceuticals, and therefore a drop in the inflammatory metabolic activity on the walls of the large vessels, which was in line with the drop in the laboratory parameters of the inflammation (FW, CRP).

Conclusion:
Positron emission tomography using 18F-FDG can be used to detect active large vessel vasculitis in patients examined for symptoms of fever of uncertain origin. Apparently, PET can detect cases of large vessel vasculitis where other imaging methods have failed and can be also used to follow the development of vasculitis activity during therapy.

Key words:
large vessel vasculitis – FDG PET – positron emission tomography – temporal arteritis – giant cell arteritis –fever of uncertain origin

Sources

1. Amberger CC, Dittman H, Overkamp D et al. Large vessel vasculitis as cause of fever (FUO) or systemic inflammation of unknown origin. Value of F-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET). Z Rheumatol 2005; 64: 32-39.

2. Andrews J, Al-Nahhas A, Pennel DJ et al. Non-invasive imaging in the diagnosis and management of Takayasu´s arteritis. Ann Rheum Dis 2004; 63: 995-1000.

3. Bakheet SM, Powel J, Ezzat A et al. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23: 739-742.

4. Belhocine T, Blockmans D, Hustinx R et al. Imaging of large vessel vasculitis with 18FDG PET illusion or reality?: A critical revuve of literature data. Eur J Nucl Med Mol Imaging 2003; 30: 1305-1315.

5. Bleeker-Rovers CP, de Kleijn EM, Corstens FH et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31: 29-37.

6. Blockmans D, De Ceuninck L, Vanderschueren S et al. Repetitive 18F-Fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55: 131-137.

7. Blockmans D, Knockaert D, Maes A et al. Clinical value of (18F)fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32: 191-196.

8. Blockmans D, Maes A, Stroobants S et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999; 38: 444-447.

9. Brodmann M, Lipp RW, Passath A et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004; 43: 241-242.

10. Buysschaert I, Vanderschueren S, Blockmans D et al. Contribution of 18fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 2004; 15: 151-156.

11. De Winter F, Petrovic M, Van De Wiele C et al. Imaging of giant cell arteritis. Evidence of splenic involvement using FDG positron emission tomography. Clin Nucl Med 2000; 25: 633-634.

12. Fletcher TM, Espinola D. Positron emission tomography in the diagnosis of giant cell arteritis. Clin Nucl Med 2004; 29: 617-619.

13. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr1999; 23: 16-18.

14. Ishimori T, Saga T, Mamede M et al. Increased 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002; 43: 6586-6563.

15. Jarůšková M, Bělohlávek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 2006; 33 (8): 913-918.

16. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.

17. Kobayshi Y, Ishii K, Oda K et al. Aortic wall inflammation due to Takayasu Arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 2005; 46: 917-922.

18. Kubota R, Yamada S, Kubota K et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.

19. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35: 1647-1649.

20. Meller J, Grabe E, Becker W et al. Value of 18-FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 2003; 13: 400-405.

21. Meller J, Strutz F, Siefker U et al. Early diagnosis and follow-up of aortitis with 18-FDGPET and MRI. Eur J Nucl Med 2003; 30: 730-736.

22. Moosig F, Czech N, Mehl C et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 2004; 63: 870-873.

23. Neuwirth J. Kompendium diagnostického zobrazování. Praha: Triton 1998, 516-551.

24. Pavelka K. Polymyalgia rheumatica a temporální arteriitida: přehledný referát. Čes Revmatol 2001; 3: 129-136.

25. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 1961; 40: 1-30.

26. Rudd JH, Warburton EA, Fryer TD et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-2711.

27. Řehák Z, Fryšáková L, Tichý T et al. Detekce temporální arteritidy pomocí 18F-FDG PET. Čes Radiol 2006; 60: 234-238.

28. Scheel AK, Meller J, Vosshenrich R et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 2004; 63: 1507-1510.

29. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG-PET imaging: physiologic and artifactual fluorodeoxyglucose accumulation. J Nucl Med 1996; 36: 441-446.

30. Turlakow A, Yeung HWD, Pui J et al. Fluorodeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001; 161: 1003-1007.

31. Walter MA, Mlezer RA, Schindler CH The value of [18F]FDG PET in the diagnosis of large vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32: 674-681.

32. Wenger M, Gasser R, Donnemiller E et al. Generalized large vessel arteritis visualised by 18fluoroglucose-positron emission tomography. Circulation 2003; 107: 923.

33. Wiest R, Glück T, Schönberger J et al. Clinical image: occult large vessel vasculitis diagnosed by PET imaging. Rheumatol Int 2001; 20: 250.

34. Zalts R, Hamoud S, Bar-Shalom R Panaortitis: diagnosis via fluorodeoxyglucose positron emission tomography. Am J Med Sci 2005; 330: 247-249.